Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Shockwave in Postoperative Breast Reconstruction Fibrosis

NCT: NCT06919042 · RECRUITING

NCT IDNCT06919042
StatusRECRUITING
Start Date2024-10-01
Completion2026-09

Brief Summary

This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis.

Frequently Asked Questions

What is Shockwave in Postoperative Breast Reconstruction Fibrosis?

Shockwave in Postoperative Breast Reconstruction Fibrosis is a clinical trial registered under NCT06919042. Current status: RECRUITING.

What is the status of NCT06919042?

The current status of NCT06919042 (Shockwave in Postoperative Breast Reconstruction Fibrosis) is: RECRUITING.

When did Shockwave in Postoperative Breast Reconstruction Fibrosis start?

Shockwave in Postoperative Breast Reconstruction Fibrosis started on 2024-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑